ENVOY MEDICAL, INC. Cost of Revenue
ENVOY MEDICAL, INC. (COCH) reported Cost of Revenue of $278.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-10
- ENVOY MEDICAL, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $278.00K, a 18.80% increase year-over-year.
- ENVOY MEDICAL, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $313.00K, a 38.50% increase year-over-year.
- ENVOY MEDICAL, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $211.00K, a 34.39% increase year-over-year.
- ENVOY MEDICAL, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $203.00K, a 8.56% increase year-over-year.
- ENVOY MEDICAL, INC. cost of goods and services sold for fiscal 2023 was $789.00K, a 58.43% increase from fiscal 2022.
- ENVOY MEDICAL, INC. cost of goods and services sold for fiscal 2022 was $498.00K.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $278.00K 10-Q · filed 2026-08-10 | $591.00K 10-Q · filed 2026-08-10 | $802.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.00M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $313.00K POS AM · filed 2026-06-12 | $524.00K derived: sum of 2 quarters · filed 2026-06-12 | $727.00K derived: sum of 3 quarters · filed 2026-06-12 | $961.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $211.00K derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12 | $414.00K derived: sum of 2 quarters · filed 2026-06-12 | $648.00K derived: sum of 3 quarters · filed 2026-08-10 | $874.00K POS AM · filed 2026-06-12 |
| 2025-09-30 | $203.00K 10-Q · filed 2025-11-10 | $437.00K derived: sum of 2 quarters · filed 2026-08-10 | $663.00K 10-Q · filed 2025-11-10 | $820.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $234.00K 10-Q · filed 2026-08-10 | $460.00K 10-Q · filed 2026-08-10 | $617.00K derived: sum of 3 quarters · filed 2026-08-10 | $804.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $226.00K POS AM · filed 2026-06-12 | $383.00K derived: sum of 2 quarters · filed 2026-06-12 | $570.00K derived: sum of 3 quarters · filed 2026-06-12 | $815.00K derived: sum of 4 quarters · filed 2026-06-12 |
| 2024-12-31 | $157.00K derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12 | $344.00K derived: sum of 2 quarters · filed 2026-06-12 | $589.00K derived: sum of 3 quarters · filed 2026-06-12 | $742.00K POS AM · filed 2026-06-12 |
| 2024-09-30 | $187.00K 10-Q · filed 2025-11-10 | $432.00K derived: sum of 2 quarters · filed 2025-11-10 | $585.00K 10-Q · filed 2025-11-10 | $819.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $245.00K 10-Q · filed 2025-07-31 | $398.00K 10-Q · filed 2025-07-31 | $632.00K derived: sum of 3 quarters · filed 2025-07-31 | $821.00K derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $153.00K 10-Q · filed 2025-05-01 | $387.00K derived: sum of 2 quarters · filed 2025-05-01 | $576.00K derived: sum of 3 quarters · filed 2025-05-01 | $738.00K derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $423.00K derived: sum of 2 quarters · filed 2025-03-31 | $585.00K derived: sum of 3 quarters · filed 2025-03-31 | $789.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $189.00K 10-Q · filed 2024-11-14 | $351.00K derived: sum of 2 quarters · filed 2024-11-14 | $555.00K 10-Q · filed 2024-11-14 | $677.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $162.00K 10-Q · filed 2024-08-12 | $337.00K 10-Q · filed 2024-08-12 | $488.00K derived: sum of 3 quarters · filed 2024-08-12 | $594.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $175.00K 10-Q · filed 2024-05-15 | $326.00K derived: sum of 2 quarters · filed 2024-05-15 | $432.00K derived: sum of 3 quarters · filed 2024-05-15 | |
| 2022-12-31 | $151.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-01 | $257.00K derived: sum of 2 quarters · filed 2024-04-01 | $498.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $106.00K 10-Q/A · filed 2024-01-17 | $347.00K 10-Q/A · filed 2024-01-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |